Supplier News: Lonza, Catalent, AGC Biologics & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, Catalent, AGC Biologics, Cellipont Bioservices, ApiJect Systems, Societal CDMO, NJII, Schott, BD, and Gerresheimer. Highlights below. Biologics Manufacturing* Lonza, Kodiak Sciences…

Mfg News: Novartis, BMS, Vertex, Gilead, UCB & More
By

By
A roundup of manufacturing news from Novartis, Bristol-Myers Squibb, Vertex Pharmaceuticals, Gilead Sciences, and UCB. Highlights below. * Novartis To Sell UK API Mfg Facility* Korean Conglomerate Lotte To Buy…

FDA Launches Program To Facilitate Rare Disease Drug Development
By

By
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) has launched a new program, the Accelerating Rare disease Cures (ARC) Program, to facilitate the development…

COVID News: Pfizer, AstraZeneca, Lilly, J&J, & More
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Pfizer, AstraZeneca, Lilly, J&J, GSK, and Novavax. Highlights below. Manufacturing and supply of COVID-19 vaccines and drugs* Pfizer, BioNTech Amend EU COVID-19…

Global Briefs: Bausch Health, ADC Therapeutics, Viatris & More
By

By
A roundup of news from Bausch Health, ADC Therapeutics, Viatris, Biocon Biologics, Emergent BioSolutions, Procaps Group, and Grupo Somar. Highlights below. * Bausch Health Names New CEO; Completes Spin-off of…

Pfizer To Acquire Biohaven Pharmaceuticals for $11.6 Bn
By

By
Pfizer has agreed to acquire Biohaven Pharmaceuticals, a bio/pharmaceutical company with lead assets for treating migraines, for approximately $11.6 billion. The pending acquisition follows the completion of a $1.24-billion licensing…

J&J Names CEO Designate of Planned Consumer Health Spin-off
By

By
Johnson & Johnson (J&J) has named Thibaut Mongon, Executive Vice President and Worldwide Chairman of Consumer Health at J&J, as CEO Designate of J&J’s to-be-spun-off, new Consumer Health company. J&J…

eureKING Launches as SPAC for Biologics CDMOs
By

By
eureKING, a special purpose acquisition company (SPAC) focused on investing in biologic-based CDMOs, mainly in Europe, has launched an initial public offering on Euronext Paris with the aim of raising…

Supplier News: Bachem, PCI, Lonza, Cytiva & More
By

By
The latest from CDMOs, CMOs, and suppliers featuring Bachem, PCI Pharma Services, Cytiva, Grifols, Lonza, Thermo Fisher, Charles River Laboratories, Bora Pharmaceuticals, Stevanato Group, Ardena, Kindeva Drug Delivery, Coriolis Pharma,…

Mfg News: Novartis, Aurobindo Pharma, & Sun Pharma
By

By
A roundup of manufacturing news from Novartis, Aurobindo Pharma, and Sun Pharma. Highlights below. * Novartis Suspends Mfg of Two Radioligand Drugs* FDA Cites Aurobindo Pharma’s Oral Dose Mfg Facility*…